• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于多参数磁共振成像的纹理特征在预测垂体生长激素腺瘤亚型中的应用价值

Usefulness of the Texture Signatures Based on Multiparametric MRI in Predicting Growth Hormone Pituitary Adenoma Subtypes.

作者信息

Liu Chen-Xi, Heng Li-Jun, Han Yu, Wang Sheng-Zhong, Yan Lin-Feng, Yu Ying, Ren Jia-Liang, Wang Wen, Hu Yu-Chuan, Cui Guang-Bin

机构信息

Department of Radiology, Tangdu Hospital, Air Force Medical University (Fourth Military Medical University), Xi'an, China.

Functional and Molecular Imaging Key Lab of Shaanxi Province, Xi'an, China.

出版信息

Front Oncol. 2021 Jul 7;11:640375. doi: 10.3389/fonc.2021.640375. eCollection 2021.

DOI:10.3389/fonc.2021.640375
PMID:34307124
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8294058/
Abstract

OBJECTIVE

To explore the usefulness of texture signatures based on multiparametric magnetic resonance imaging (MRI) in predicting the subtypes of growth hormone (GH) pituitary adenoma (PA).

METHODS

Forty-nine patients with GH-secreting PA confirmed by the pathological analysis were included in this retrospective study. Texture parameters based on T1-, T2-, and contrast-enhanced T1-weighted images (T1C) were extracted and compared for differences between densely granulated (DG) and sparsely granulated (SG) somatotroph adenoma by using two segmentation methods [region of interest 1 (ROI), excluding the cystic/necrotic portion, and ROI, containing the whole tumor]. Receiver operating characteristic (ROC) curve analysis was performed to determine the differentiating efficacy.

RESULTS

Among 49 included patients, 24 were DG and 25 were SG adenomas. Nine optimal texture features with significant differences between two groups were obtained from ROI. Based on the ROC analyses, T1WI signatures from ROI achieved the highest diagnostic efficacy with an AUC of 0.918, the accuracy, sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were 85.7, 72.0, 100.0, 100.0, and 77.4%, respectively, for differentiating DG from SG. Comparing with the T1WI signature, the T1C signature obtained relatively high efficacy with an AUC of 0.893. When combining the texture features of T1WI and T1C, the radiomics signature also had a good performance in differentiating the two groups with an AUC of 0.908. In addition, the performance got in all the signatures from ROI was lower than those in the corresponding signature from ROI

CONCLUSION

Texture signatures based on MR images may be useful biomarkers to differentiate subtypes of GH-secreting PA patients.

摘要

目的

探讨基于多参数磁共振成像(MRI)的纹理特征在预测生长激素(GH)垂体腺瘤(PA)亚型中的应用价值。

方法

本回顾性研究纳入49例经病理分析确诊为分泌GH的PA患者。采用两种分割方法[感兴趣区域1(ROI),不包括囊性/坏死部分,以及ROI,包含整个肿瘤],提取基于T1加权、T2加权和对比增强T1加权图像(T1C)的纹理参数,并比较密集颗粒型(DG)和稀疏颗粒型(SG)生长激素腺瘤之间的差异。进行受试者操作特征(ROC)曲线分析以确定鉴别效能。

结果

49例纳入患者中,24例为DG腺瘤,25例为SG腺瘤。从ROI获得了9个两组间有显著差异的最佳纹理特征。基于ROC分析,ROI的T1WI特征诊断效能最高,AUC为0.918,区分DG与SG的准确性、敏感性、特异性、阳性预测值(PPV)和阴性预测值(NPV)分别为85.7%、72.0%、100.0%、100.0%和77.4%。与T1WI特征相比,T1C特征的效能相对较高,AUC为0.893。当结合T1WI和T1C的纹理特征时,影像组学特征在区分两组方面也有良好表现,AUC为0.908。此外,ROI所有特征的表现均低于相应的包含整个肿瘤的ROI特征。

结论

基于MR图像的纹理特征可能是区分分泌GH的PA患者亚型的有用生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02bd/8294058/b49903fcc656/fonc-11-640375-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02bd/8294058/109aece021cc/fonc-11-640375-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02bd/8294058/1ce35c2ab3f1/fonc-11-640375-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02bd/8294058/12381ec16f2e/fonc-11-640375-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02bd/8294058/7fdc05dd4a01/fonc-11-640375-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02bd/8294058/b49903fcc656/fonc-11-640375-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02bd/8294058/109aece021cc/fonc-11-640375-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02bd/8294058/1ce35c2ab3f1/fonc-11-640375-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02bd/8294058/12381ec16f2e/fonc-11-640375-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02bd/8294058/7fdc05dd4a01/fonc-11-640375-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02bd/8294058/b49903fcc656/fonc-11-640375-g005.jpg